Within a short span of 2 years, 4 major biomedical companies announced their commercial-scale biologics manufacturing investments in Singapore. These investments include, GlaxoSmithKline’s Biologics’ vaccine plant, Lonza’s two mammalian cell culture facilities, Novartis cell culture plant and Genentech microbial facility.
So what made these companies come to Singapore?
Firstly, it was due to the country’s heavy investments [...]

How long do you think it takes from the time the drug is discovered to the time it comes in the market?
In 2002, survey found that the average time for the development of a drug is about 12 years and 10 months, and only 1 in 10 drugs are able to make it to the [...]

Come and be part of our team to forge the Biofuture!
-Prof Miranda Yap Executive Director, BTI

What is BTI?
The Bioprocessing Technology Institute (BTI) is one of the institutes under the Agency of Science, Technology and Research (A*Star).  At BTI, researchers and scientists pursue innovative and cutting-edge research in bioprocess and engineering that develop technologies to impact [...]

“Every patient is special.”

This is the foundation behind drug development and production. The pharmaceutical industry has to follow heavy regulations and guidelines to ensure the products are safe for consumption and the process adopted for manufacturing is reliable. The nature of this industry calls for the highest standards of production precision and accurate product and [...]

A*STAR’s Bioprocessing Technology Institute (BTI) and GSK Biologicals SA Belgium have recently sealed an agreement to collaborate in three vaccine and adjuvant system related research projects. This partnership aims to bring new approaches to vaccine development and production.
With biologics becoming increasingly profitable with growth in sales doubling that of traditional pharmaceuticals, BTI’s work on characterizing [...]